Ellis V. E.
- Country
- The Netherlands
- Department
- Neurology
Research Overview
- Evaluation of Intrathecal ALN-APP Efficacy and Safety in Cerebral Amyloid Angiopathy: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Acetylsalicylic Acid and Clopidogrel Monotherapy for Secondary Prevention in Intracerebral Hemorrhage Survivors: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 1 of 27 partner sites.
Specializations
Neurological Disorders
The investigator specializes in studying Cerebral Amyloid Angiopathy (CAA), a complex neurological condition affecting brain blood vessels. Their research focuses on understanding and treating amyloid protein accumulation in cerebral vasculature.
- Brain Vessel Pathology
- Amyloid-Related Disorders
- Cerebral Microbleeds
This clinical research explores innovative therapeutic approaches for managing CAA-related complications.
Vascular Medicine
The investigator's work centers on cerebrovascular conditions with particular attention to blood vessel integrity and brain hemorrhage prevention. Their expertise extends to examining vascular wall pathologies.
- Blood Vessel Wall Disorders
- Cerebral Hemorrhage
- Vascular Protection
Their research encompasses evaluation of novel therapeutic agents targeting vascular amyloid accumulation.
Therapeutic Development
The investigator evaluates novel therapeutic approaches for treating cerebral vascular disorders. Their work includes assessment of experimental treatments for amyloid-related conditions.
- Safety Assessment
- Clinical Tolerability
- Treatment Innovation
Their research aims to advance therapeutic options for patients with cerebrovascular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.